Table 1. Co-purified mRNAs enriched in eluates relative to input extracts.
Rank | Fold Enrichment | Symbol | Gene Name |
1,10 | 14.2 | Myh10 | Non-muscle myosin IIb |
2,11 | 12.9 | Flnb | Filamin B |
3,50 | 12.55 | Dbn1 | Drebrin |
4,9,28,86 | 12.4 | Svil | Supervillin |
5,40 | 11.14 | Ppp1r9a | Neurabin I |
6,13,36 | 10.61 | Spnb2 | Spectrin β2 |
7,50 | 10.33 | Utrn | Utrophin |
8,19 | 10.06 | Plec1 | Plectin |
12,65 | 9.14 | 2900026A02Rik | Riken cDNA 2900026A02 gene |
14 | 8.04 | Cgn | Cingulin |
15,16 | 7.42 | Lima1 | Eplin/Lim domain and actin binding 1 |
17 | 6.44 | St5 | Supp. of tumorigenicity 5 |
18,37 | 6.24 | Cgnl1 | Cingulin-like |
20 | 6.05 | Aim1 | Absent in Melanoma 1 |
21 | 5.79 | Flna | Filamin A |
22 | 5.54 | Myo6 | Myosin VI |
23,24,29 | 5.46 | Actn4 | α-Actinin-4 |
25 | 4.89 | Nes | Nestin |
26,31 | 4.86 | Iqgap1 | IG motif GTPase activating protein |
27 | 4.85 | Fbxo34 | F-box only protein 34 |
30 | 4.27 | Specc1 | Sperm antigen with calponin homology and coiled-coil domains 1 |
32 | 4 | C430004E15Rik | Riken cDNA C430004E15 gene |
33 | 3.87 | Mical3 | Microtubule associated monoxygenase, calponin and LIM domain 3 |
34,39 | 3.85 | Spna2 | Spectrin α2/α-Fodrin |
35,46,47,55 | 3.8 | Dst | Dystonin |
38 | 3.71 | Myo1e | Myosin 1e |
41,83 | 3.63 | Actn1 | α-Actinin-1 |
42 | 3.54 | Myo18a | Myosin XVIIIa |
43 | 3.33 | Flnc | Filamin C |
44 | 3.29 | Myh9 | Non-muscle myosin IIa |
45 | 3.27 | Eppk1 | Epiplakin |
48 | 2.93 | Dmn | Desmuslin |
49,59 | 2.83 | Lmo7 | Lim domain only 7 |
51,57 | 2.7 | Myo5a | Myosin heavy chain 12 |
52 | 2.64 | Ppp1r9b | Neurabin II/Spinophilin |
53 | 2.64 | Fbxo46 | F-box only 46 |
54 | 2.63 | cep350 | Centrosome associated protein 350 |
58 | 2.53 | Pls3 | T-Plastin/T-Fimbrin |
60,70 | 2.5 | Smtn | Smoothelin |
61 | 2.45 | Zfp185 | Zinc finger protein 185 |
62 | 2.42 | Myo1b | Myosin Ib |
63,66 | 2.4 | Gas2l3 | Growth arrest specific 2-like 3 |
64 | 2.37 | Crocc | Rootletin |
67 | 2.29 | Shrm | Shroom |
68 | 2.29 | Incenp | Inner centromere protein |
69,75 | 2.27 | Baz1a | Bromodomain adjacent to zinc finger domain 1A |
71 | 2.22 | Myo1d | Myosin 1d |
72 | 2.22 | Supt6h | Suppressor of Ty 6 homolog |
73 | 2.21 | 2610015P09Rik | Riken cDNA 2610015P09 gene |
74 | 2.2 | Gsn | Gelsolin |
77 | 2.2 | Dnmt1 | DNA methyltransferase 1 |
78 | 2.18 | Ppp1r8 | Protein phosphatase 1 regulatory inhibitor subunit 8 |
79 | 2.17 | Cspp1 | Centrosome and spindle pole associated protein |
80 | 2.14 | Crybb3 | Crystallin B3 |
81 | 2.14 | Zc3h13 | Zinc finger CCCH-type containing 13 |
82 | 2.14 | Pprc1 | Peroxisome proliferator-activated receptor gamma, coactivator-related 1 |
84 | 2.05 | Arhgap23 | Rho GTPase activating protein |
85 | 2.03 | Ogdh | Oxoglutarate dehydrogenase (lipoamide) |
87 | 2.03 | Mcm7 | Minichromosome maintenance deficient |
88 | 2.01 | Tmod3 | Tropomodulin 3 |
List of genes that passed the 15% FDR cutoff and were more than two-fold enriched. The rank column also lists genes with multiple corresponding probesets. For genes with multiple probesets in the list, the fold change for the highest ranked probeset is shown. For the complete list of all genes with the corresponding fold changes see Table S1.